825 Regression of left ventricular hypertrophy in patients with fabry cardiomyopathy during long term enzyme replacement therapy - the impact of the baseline conditions | Zendy

AI Assistant Blog Pricing

825 Regression of left ventricular hypertrophy in patients with fabry cardiomyopathy during long term enzyme replacement therapy - the impact of the baseline conditions

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.